Tristel Cash Flow Conversion Efficiency
Tristel cash flow conversion efficiency. Based on the latest financial reports, Tristel (TSTL) has a cash flow conversion efficiency ratio of 0.161x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX5.41 Million ≈ $657.75 USD) by net assets (GBX33.55 Million ≈ $4.08K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Tristel (2004–2025)
Cash flow conversion efficiency of Tristel from 2004 to 2025. This chart illustrates how Tristel's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Tristel stock price for real-time trading data and today's change.
Tristel Cash Flow Conversion Ratio Explained
Tristel cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Tristel Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tristel ranked by their cash flow conversion efficiency. Also see TSTL market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Yowie Group Ltd
AU:YOW
|
-0.091x |
|
Nobel29 Resources Corp
V:NBLC
|
0.055x |
|
TECH INVEST GROUP ZY-02
F:6N2
|
0.044x |
|
Plaza Centers NV
WAR:PLZ
|
0.001x |
|
Streamline Health Solutions Inc
NASDAQ:STRM
|
-0.088x |
|
Siti Networks Limited
NSE:SITINET
|
-0.072x |
|
QMC Quantum Minerals Corp
V:QMC
|
0.001x |
|
Laxmi Cotspin Limited
NSE:LAXMICOT
|
0.025x |
Annual Cash Flow Conversion Efficiency for Tristel (2004–2025)
The table below shows the annual cash flow conversion efficiency of Tristel from 2004 to 2025. Review TSTL free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | GBX32.99 Million ≈ $4.01K |
GBX10.32 Million ≈ $1.26K |
0.313x | -6.90% |
| 2024-06-30 | GBX32.41 Million ≈ $3.94K |
GBX10.89 Million ≈ $1.32K |
0.336x | +21.39% |
| 2023-06-30 | GBX30.68 Million ≈ $3.73K |
GBX8.49 Million ≈ $1.03K |
0.277x | +44.43% |
| 2022-06-30 | GBX28.99 Million ≈ $3.53K |
GBX5.55 Million ≈ $675.64 |
0.192x | -11.04% |
| 2021-06-30 | GBX30.08 Million ≈ $3.66K |
GBX6.48 Million ≈ $788.19 |
0.215x | -12.30% |
| 2020-06-30 | GBX28.46 Million ≈ $3.46K |
GBX6.99 Million ≈ $850.36 |
0.246x | +4.55% |
| 2019-06-30 | GBX23.36 Million ≈ $2.84K |
GBX5.49 Million ≈ $667.49 |
0.235x | -3.72% |
| 2018-06-30 | GBX18.43 Million ≈ $2.24K |
GBX4.50 Million ≈ $546.91 |
0.244x | -9.97% |
| 2017-06-30 | GBX16.06 Million ≈ $1.95K |
GBX4.35 Million ≈ $529.51 |
0.271x | -10.89% |
| 2016-06-30 | GBX14.96 Million ≈ $1.82K |
GBX4.55 Million ≈ $553.60 |
0.304x | +64.89% |
| 2015-06-30 | GBX14.16 Million ≈ $1.72K |
GBX2.61 Million ≈ $317.80 |
0.184x | -31.92% |
| 2014-06-30 | GBX12.08 Million ≈ $1.47K |
GBX3.27 Million ≈ $397.99 |
0.271x | +315.55% |
| 2013-06-30 | GBX10.88 Million ≈ $1.32K |
GBX709.00K ≈ $86.26 |
0.065x | -46.03% |
| 2012-06-30 | GBX12.41 Million ≈ $1.51K |
GBX1.50 Million ≈ $182.38 |
0.121x | +4897.80% |
| 2011-06-30 | GBX11.92 Million ≈ $1.45K |
GBX-30.00K ≈ $-3.65 |
-0.003x | -101.73% |
| 2010-06-30 | GBX8.49 Million ≈ $1.03K |
GBX1.24 Million ≈ $150.26 |
0.145x | -25.98% |
| 2009-06-30 | GBX4.83 Million ≈ $587.18 |
GBX948.00K ≈ $115.34 |
0.196x | +58.43% |
| 2008-06-30 | GBX4.32 Million ≈ $525.01 |
GBX535.00K ≈ $65.09 |
0.124x | -70.70% |
| 2007-06-30 | GBX2.63 Million ≈ $319.99 |
GBX1.11 Million ≈ $135.42 |
0.423x | +163.51% |
| 2006-06-30 | GBX2.00 Million ≈ $243.95 |
GBX322.00K ≈ $39.18 |
0.161x | +0.54% |
| 2005-06-30 | GBX1.68 Million ≈ $204.89 |
GBX269.00K ≈ $32.73 |
0.160x | +110.65% |
| 2004-04-30 | GBX-154.00K ≈ $-18.74 |
GBX231.00K ≈ $28.11 |
-1.500x | -- |
About Tristel
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for … Read more